Review highlights changes in the diagnosis, management of desmoplastic melanoma

  • April 19, 2014

NEW YORK – Merrick I. Ross, MD, discusses recent studies which highlighted possible treatment changes for desmoplastic melanoma, a relatively rare variant of malignant melanoma that exhibits distinct clinical behavior from non-desmoplastic melanoma.

While the overall prognosis for patients with desmoplastic melanoma is believed to be favorable vs. patients with conventional melanoma subtypes, some investigators have suggested that local recurrence rates for desmoplastic melanoma are higher than for conventional melanoma. Merrick also debates the importance of aggressive local therapy in determining the overall disease-specific outcomes for patients with this malignancy.

More »

Additional headlines from HemOnc Today Melanoma and Cutaneous Malignancies meeting

See All »